Profiling the epithelial‐mesenchymal transition‐related molecular markers demonstrated decreased CDH1, TJP1, and OCLN and increased ZEB1, FN1, and EZH2 in response to CDKN2A silencing in lung cancer cells. The gene discussed is EZH2; the disease is lung carcinoma.